Cargando…
Maintained partial protection against Streptococcus pneumoniae despite B‐cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine
OBJECTIVES: Anti‐CD20 monoclonal antibody therapy rapidly depletes > 95% of CD20(+) B cells from the circulation. B‐cell depletion is an effective treatment for autoimmune disease and B‐cell malignancies but also increases the risk of respiratory tract infections. This effect on adaptive immunity...
Autores principales: | Ercoli, Giuseppe, Ramos‐Sevillano, Elisa, Pearce, Emma, Ragab, Sara, Goldblatt, David, Weckbecker, Gisbert, Brown, Jeremy S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715227/ https://www.ncbi.nlm.nih.gov/pubmed/35003749 http://dx.doi.org/10.1002/cti2.1366 |
Ejemplares similares
-
The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae
por: Ercoli, Giuseppe, et al.
Publicado: (2021) -
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge
por: Chan, Win-Yan, et al.
Publicado: (2019) -
Corrected and Republished from: “A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge”
por: Chan, Win-Yan, et al.
Publicado: (2022) -
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
por: Morais, Victor, et al.
Publicado: (2022) -
Semisynthetic
Pneumococcal Glycoconjugate Nanovaccine
por: Prasanna, Maruthi, et al.
Publicado: (2023)